Randomized controlled trial of a novel digital health solution to enable remote fetal monitoring in high risk pregnancies

新型数字健康解决方案的随机对照试验,可在高风险妊娠中实现远程胎儿监测

基本信息

  • 批准号:
    10242470
  • 负责人:
  • 金额:
    $ 76.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-20 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Women carrying high risk pregnancies require frequent, in-person fetal monitoring appointments to reduce their risk of stillbirth. However, public health emergencies, such as the COVID-19 pandemic, lead to reduced access to care access and elevated risk of infectious exposures, that disparately impact these women. These secondary effects are even more challenging for underserved and disadvantaged women, for whom the economic and logistic barriers to multiple visits can prove insurmountable. For example, Black women face increased risk of stillbirth as well as of COVID-19 complications, while simultaneously facing more significant barriers to care such as transportation costs, childcare and employment inflexibility. Telehealth solutions have been shown to improve access to prenatal care while reducing racial disparities. Unfortunately, no digital solution has been successfully implemented to enable remote fetal monitoring for high risk pregnancies. Over the past 3 years, we have conducted validation trials of a novel, device and digital platform, called Invu, which uses bio-potential and acoustic sensors to passively detect maternal and fetal heart rate via a wearable, self-administered belt. This platform was just recently approved by the FDA for detecting fetal heart rate as part of a virtual prenatal care visit. However, we recently validated a novel algorithm for detecting uterine contractions using Invu, using the amplitude modulation of maternal signals. The addition of uterine activity monitoring provides Invu with all of the components to remotely conduct a non-stress test (NST), one of the most common fetal surveillance tests used to reduce the risk of stillbirth. However, prior devices have failed to achieve widespread uptake. Thus, it is critical to deploy a deliberate, strategic and multi-faceted approach to implementing a remote NST monitoring solution to maximize its widespread dissemination. We have gathered a multi-disciplinary team of investigators experienced in behavioral and communal interventions, health disparities, innovation methodologies, maternal fetal medicine, clinical trial design and implementation science. We will gather robust stakeholder feedback from patients, providers and clinical team members and utilize the valuable perspective to inform a workflow optimization process using rapid-cycle innovation techniques. This will allow us to preemptively identify and address potential barriers to implementation. We will then conduct a rigorous hybrid, randomized controlled trial that will first focus on demonstrating the effectiveness of a remote NST program to improve patient adherence, with specific attention to ensure that barriers faced by Black women are being addressed. At the same time, we will use a mixed methods strategy, via validated surveys and structured interviews, to study the key factors to widespread implementation and deployment. With 1 million high risk pregnancies delivering annually in the US, an effective remote NST monitoring can have profound positive impact on high risk obstetric health care delivery in the US.
项目摘要 携带高危妊娠的妇女需要频繁的亲自胎儿监测预约,以减少 死胎的风险。然而,突发公共卫生事件,如COVID-19大流行, 获得护理的机会和感染风险的增加,这对这些妇女产生了严重影响。这些 对得不到充分服务和处境不利的妇女来说, 多次访问的经济和后勤障碍可能无法克服。例如,黑人妇女面临 死产和COVID-19并发症的风险增加,同时面临更严重的 交通费用、儿童保育和就业不灵活等护理障碍。远程医疗解决方案具有 已被证明可以改善产前护理的获得,同时减少种族差异。不幸的是,没有数码 已经成功地实施了一种解决方案,以使得能够对高危妊娠进行远程胎儿监测。 在过去的3年里,我们对一种名为Invu的新型设备和数字平台进行了验证试验, 其使用生物电位和声学传感器通过可穿戴设备被动地检测母亲和胎儿的心率, 自我管理的腰带这个平台最近刚刚被FDA批准用于检测胎儿心率, 虚拟产前检查然而,我们最近验证了一种新的算法,用于检测子宫 收缩使用Invu,使用母体信号的幅度调制。子宫活动的增加 监控为Invu提供了远程进行非压力测试(NST)的所有组件, 最常见的胎儿监测测试用于降低死胎的风险。然而,先前的装置未能 实现广泛吸收。因此,采取深思熟虑、战略性和多方面的方法至关重要, 实施远程NST监测解决方案,以最大限度地扩大其广泛传播。 我们召集了一个多学科的调查小组,他们在行为和社区方面经验丰富, 干预措施,健康差距,创新方法,母婴医学,临床试验设计和 执行科学。我们将从患者、医疗服务提供者和临床团队收集强大的利益相关者反馈 成员,并利用有价值的观点,通知工作流程优化过程,使用快速循环 创新技术。这将使我们能够先发制人地识别和解决潜在的障碍, 实施.然后,我们将进行一项严格的混合随机对照试验, 证明远程NST计划在提高患者依从性方面的有效性, 确保黑人妇女面临的障碍得到解决。同时,我们将使用混合 方法策略,通过有效的调查和结构化访谈,研究关键因素,以广泛 实施和部署。在美国,每年有100万高危妊娠分娩, 远程NST监测可以对美国的高风险产科卫生保健提供产生深远的积极影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nadav Schwartz其他文献

Nadav Schwartz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nadav Schwartz', 18)}}的其他基金

Randomized controlled trial of a novel digital health solution to enable remote fetal monitoring in high risk pregnancies
新型数字健康解决方案的随机对照试验,可在高风险妊娠中实现远程胎儿监测
  • 批准号:
    10490447
  • 财政年份:
    2021
  • 资助金额:
    $ 76.13万
  • 项目类别:
Randomized controlled trial of a novel digital health solution to enable remote fetal monitoring in high risk pregnancies
新型数字健康解决方案的随机对照试验,可在高风险妊娠中实现远程胎儿监测
  • 批准号:
    10682538
  • 财政年份:
    2021
  • 资助金额:
    $ 76.13万
  • 项目类别:
Placental morphology and serum biomarkers to predict adverse pregnancy outcome
胎盘形态和血清生物标志物可预测不良妊娠结局
  • 批准号:
    8302096
  • 财政年份:
    2012
  • 资助金额:
    $ 76.13万
  • 项目类别:
Placental morphology and serum biomarkers to predict adverse pregnancy outcome
胎盘形态和血清生物标志物可预测不良妊娠结局
  • 批准号:
    8442815
  • 财政年份:
    2012
  • 资助金额:
    $ 76.13万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 76.13万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 76.13万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 76.13万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 76.13万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 76.13万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 76.13万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 76.13万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 76.13万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 76.13万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 76.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了